baber/WOPTO huggingface dataset:
Patent JP-H11507098-A (JP)
Title: キレート化剤含有の噴霧乾燥された成分
IPC: C11D7/36
Filed: 1997-03-21
Abstract: (57)【要約】
本発明は、ｉ）少なくとも５０重量％、好ましくは少なくとも６０重量％、のキレート化剤、ｉｉ）１重量％〜２５重量％、好ましくは５重量％〜１０重量％、のアルカリ金属またはアルカリ土類金属の硫酸塩、およびｉｉｉ）好ましくは１０重量％より少ない遊離湿分、を含んでなる、高いキレート化剤活性を有する、自由流動性の粒子形態の噴霧乾燥された成分、に関する。
Patent JP-2000502719-A (JP)
IPC: C07C45/33
Filed: 1997-03-27
Abstract: Processes are disclosed for the oxidation of alkanes such as, for example, propane, to form unsaturated carboxylic aldehydes and acids such as, for example, acrolein and acrylic acid. The processes utilize oxygen and recycle alkanes, e.g., propane, to the aldehyde reactor. The presence of the alkene in the alkene-to-aldehyde reaction can enhance the efficiency of the processes.
Patent JP-2000509803-A (JP)
Title: 流体式衝突緩衝器
IPC: F01L9/20
Filed: 1998-02-14
Abstract: (57)【要約】
本発明は、固定された部品の衝突面に対する可動部品（８）の当接を緩衝するための要素に関する。この場合、緩衝要素はピストン（１１）とシリンダ（１０）を備え、このピストンとシリンダは少なくとも１個の戻しばね（１２，２７）の力に抗して静止位置から相対的に移動可能に案内されている。シリンダ（１０）の両端はそれぞれ流体室（１７）に接続されている。流体室（１７）は少なくとも１つの流路（１８）と少なくとも１つの絞り通路（１６）を介して接続され、この流路（１８）は逆止弁（１９）を備え、この逆止弁は静止位置からの相対運動時に閉じる。
Patent JP-2001507167-A (JP)
Title: 有機発光ダイオード用のアノード改質
IPC: H01L51/50
Filed: 1998-02-02
Abstract: (57)【要約】
カソード（５１）と、アノード（４８、４７、４６）と、前記アノードとカソードとの間に電圧が印加された場合にそこでエレクトロルミネセンスが発生する有機領域（５０、４９）とを含む有機発光デバイスを提供する。アノードは、金属層（４６）と、障壁層（４７）と、アノード改質層（４８）とを含む。カソード（５１）により光が放出される。
Patent JP-H11509681-A (JP)
Title: ハンドルロック装置を備えた回路遮断器
IPC: H01H33/46
Filed: 1997-05-14
Abstract: (57)【要約】
本発明はスイッチハンドルの運動を阻止する電気スイッチロック組立体に関する。スイッチハンドルは、ケーシングまたはハウジングに内蔵され、回路を開閉する電気接点を開閉するため第１および第２位置の間の通路に沿って作動的に移動する。第１および第２凹所が、スイッチハンドルの通路を横切ってロック装置をうけ入れるため、ケーシングにモールドされる。ロック装置は、はさみのように枢着された第１および第２脚部を有する。第１脚部は第２脚部から離れる方向に突出する一体の第１足部を有し、第２脚部は第１脚部から離れる方向に突出する一体の第２足部を有し、はさみのように先端は反対方向に突出する。第１および第２脚部は、いくぶんはさみのハンドルのように、それぞれ第１および第２足部と反対側に開口を有する。第１足部は第１凹所に挿入され、第２足部は第２凹所に挿入される。南京錠またはねじのような、ロック軸が凹所と係合した脚部を保持するため、開口に固定される。かくしてロック装置は、スイッチハンドルの運動通路を横切って、スイッチハンドルが所望の位置にロックされるように、係合せしめられる。こうして、回路は変化が承認されるまで、消勢または付勢のいずれかのままの状態に保持される。
Patent JP-2000513083-A (JP)
Title: 摺動リングシール
IPC: F16J15/34
Filed: 1998-03-24
Abstract: (57)【要約】
本発明は、CO 2 とオイルの混合物を含む空調コンプレッサハウジングに対して、高圧下において、CO 2 冷媒コンプレッサのモーターシャフトを密封するための摺動リングシールに関する。摺動リングシールは、動作中に、シールギャッブを形成し、互いに接触するシール面（１０）（９）をそれぞれ有する２つの摺動リング（５）（７）を備えている。２つの摺動リング（５）（７）は、焼結硬質材料で形成され、特別な組成、機械的特徴、及び構造を有している。
Patent JP-2001519016-A (JP)
Title: ２つの管を接続するためのリングクランプ
IPC: F16L23/04
Filed: 1998-03-26
Abstract: (57)【要約】
開示されたリングクランプは２つの半割シェル（１０，２０）を有し、各半割シェルは、外方に延びるベアリングパッド（１２，２２）を備えた第１端部と、接続手段の要素（１４，２２）の一方を備えた第２端部とを有する。接続手段は半割シェルの２つの第２端部を接続するのに使用される。半割シェルの断面はほぼＵ字形で、内方に延びるＵ字の枝部を備え、２つの管の端部の突出支持面と協働する容量を有する。クランプは、締付けボルト（３０）を有し、そのねじ部（３２）はベアリングパッド（１２，２２）の貫通孔に挿通されている。ねじ部の長さ（Ｌ）は閉じられたときのリングクランプの半径（Ｒ）に少なくともほぼ等しい。ねじ部は、ベアリングパッドの孔に緩く挿入されている。接続手段の要素（１４，２４）は、第２の半割シェルの端部を互いに引き寄せるために一体になり、端部を離れた状態に保持するために分離される。一方、ボルトのねじ部は、ベアリングパッドの孔に保持される。
Patent JP-2001526811-A (JP)
Title: Ｐｃｉバスの情報転送制御のためのウィンドウ機構
IPC: G06F13/36
Filed: 1998-05-12
Abstract: (57)【要約】
ＰＣＩトライステートバスに接続されたデバイスに無効データが伝搬するのを防ぐ方法および装置が提供される。この方法および装置は、ＰＣＩバス制御信号を用いて、バストランザクションのモード（例えば、バスターゲットとしてであるか、または、バスマスタとしてであるか）、タイプ（例えば、読み出し、書き込み）、および状態（例えば、進行中のバストランザクション）をモニタする。これらの情報を用いて、ウィンドウゲートハードウェアの開閉を制御し、ＰＣＩトライステートバスに接続されたデバイスに有効データが伝搬することを可能にし、且つ、このデバイスに無効データが伝搬するのを防ぐ。
Patent MD-20040092-A (MD)
Inventor: ARSENE ION
IPC: F03D1/00
Filed: 2004-04-22
Abstract: Inventia se refera la instalatiile pentru transformarea energiei vantului in energie mecanica, care poate fi folosita pentru producerea energiei electrice.Motorul eolian contine un arbore orizontal (1) si balansiere (2) cu palete (3). Pe arborele orizontal este fixat un butuc (4), pe care sunt montate articulat cu inclinatie balansiere cu palete. Balansierele sunt unite articulat prin brate (5) cu o bucsa canelata (6). De alta parte bucsa canelata contacteaza cu un arc (7) montat pe arbore, forta caruia este reglata cu o piulita (8). Intre butuc si bucsa canelata pe arbore este montat un arc de tampon sau o perna de soc (9). Arborele orizontal este montat pe lagare (10) si fixat pe un cap turnant (11), dotat cu role (12), care se deplaseaza liber pe suprafata laterala a unui inel de reazem (13), fixat orizontal pe capatul unui turn de tip ferma (14). Sub inelul de reazem este montat un colector de curent (15). Electrogeneratorul (16) este fixat pe capul turnant si este cuplat printr-o transmisie (17) cu arborele orizontal.Rezultatul consta in majorarea randamentului si asigurarea posibilitatii de functionare a motorului eolian in orice conditii meteorologice.
Patent NZ-207021-A (NZ)
Title: Ribbed roof tile with top ridge and bottom lip
Inventor: STUDWELL K A R
IPC: E04D3/30
Filed: 1984-02-02
Abstract: A roof cladding element which is constructed to span at least two roof framing rafters (29) and which, in use, avoids the need for conventional roofing battens. The cladding element is pressed from sheet steel and includes a panel portion (11), an inverted channel-shaped ridge (15) formed along the top edge of the panel portion, a scalloped downwardly extending lip (14) formed along the bottom edge of the panel portion, and a plurality of inverted channel-shaped ribs (16) formed in the panel portion to extend to the bottom edge from an inner wall (22) or the ridge (15). Also, a series of recesses (25) are formed in the inner wall (22) of the ridge, each recess being an alignment with one of the ribs (16) and defining a cavity into which the associated rib extends.
Patent NZ-221797-A (NZ)
Title: Disposable connector and assembly utilising the connector
Inventor: MALMBORG BENGT EBER
IPC: A61M/
Filed: 1987-09-14
Abstract: A disposable assembly comprises a drug container (2) having at one end an opening which is surrounded by an outwardly directed flange (7). A connector (1) has a sleeve (13) which is closed (14) at one end and open at its opposite end to receive the flanged end of the drug container as a plunger. Positioning means (18,19) provided within the sleeve and cooperating with the flange define an inserted and a retracted position of said sleeve relative to the flanged end of the drug container. A piercing member (15) provided at the closed end of the sleeve is directed towards the open sleeve end. A connecting member (16) provided at the closed sleeve end is directed opposite to said piercing member (15) and communicating therewith by means of a through passage (17).
Patent NZ-228558-A (NZ)
Title: Sonic generator
Inventor: NYBERG CHRISTOPHER A
IPC: B02C17/08
Filed: 1989-03-31
Abstract: A sonic generator comprises a resonant bar (11), a housing (20) and magnetic excitation (13) units connected between the resonant bar (11) and the housing (20). The magnetic excitation units (13) are connected to the bar (11) at highly stressed points using a mounting connection (14) which is a sleeve having an inside diameter slightly greater than the outside diameter of the bar (11). A resilient elastomer (21) such as urethane is mounted between the sleeve (14) and the resonant member (11). The sonic generator may be used for grinding purposes and, in particular, may be used to grind material exceptionally fine with reduced power consumption. The bar (11) is substantially unrestrained so as to allow substantially free vibration. <IMAGE>
Patent NZ-228636-A (NZ)
Title: Aminopropanol derivatives and their pharmaceutical compositions
Inventor: ROBERTSON DAVID WAYNE
IPC: C07C235/00
Filed: 1989-04-06
Abstract: The present invention provides 3-(4-substitutedphenoxy)-3-phenyl propanamines capable of inhibiting the uptake of serotonin.
Patent NZ-235427-A (NZ)
Title: Phosphonate-substituted-2-aminoalk-3-enoic acid derivatives and pharmaceutical compositions
Inventor: ANGST CHRISTOF
IPC: C07F9/59
Filed: 1990-09-24
Abstract: Substituted 2-aminoalk-3-enoic acid derivatives of the formula I <IMAGE> process for the preparation of unsaturated amino carboxylic acid derivatives of the formula I <IMAGE> in which R1 is an aliphatic or via a C atom bonded oxacycloaliphatic or optionally aliphatically N-substituted or N-acylated azacycloaliphatic hydrocarbon radical which is substituted by optionally acylated or aliphatically or araliphatically etherified hydroxyl, by halogen, by optionally acylated and/or aliphatically substituted amino or by an aza-, diaza-, azoxa- or oxacycloaliphatic radical, and R2 is free or esterified carboxyl, and their salts have a pronounced and selective antagonistic action on N-methyl-D-aspartic acid-sensitive (NMDA-sensitive) excitatory amino-acid receptors. They are prepared, for example, by, in a compound of the formula II <IMAGE> in which Z1, Z2 are optionally protected hydroxyl, Z3 is an aliphatic or via a C atom bonded oxacycloaliphatic or optionally protected or aliphatically N-substituted or N-acylated azacycloaliphatic hydrocarbon radical which is substituted by optionally protected or acylated or aliphatically or araliphatically etherified hydroxyl, by halogen, by optionally protected or acylated and/or aliphatically substituted amino or by an aza-, diaza-, azoxa- or oxacycloaliphatic radical, and Z4 is protected amino, converting protected amino Z4 and, where present, as component of Z3 into amino and, where present, protected hydroxyl Z1, Z2 and/or as component of Z3 into hydroxyl, and, where present, liberating a protected azacycloaliphatic hydrocarbon radical Z3 and, if required, converting a resulting compound into another compound of the formula I, fractionating a mixture of isomers obtainable according to the process into the components, and separating off the isomer which is preferred in each case, and/or converting a free compound obtainable according to the process into a salt or a salt obtainable according to the process into the corresponding free compound.
Patent NZ-245618-A (NZ)
Title: Therapeutic proteins microencapsulated in absence of organic solvents and oral administration of compositions containing these
Inventor: MICHAEL J GABRIEL
IPC: A61K9/52
Filed: 1993-01-06
Abstract: An orally administrable therapeutic protein is provided by combining the therapeutic protein with a stabilizing agent in an aqueous solution. The solution is coated onto nonpareils and microencapsulated with a water emulsifiable enteric coating composition. The microcapsules are orally administered. The coating protects the protein as it passes through the stomach. Upon reaching the small intestines, the basic pH of the intestinal juices will dissolve the coating, allowing the protein to be released and induce antigen specific immune response which has the specificity of the native molecule. The stabilizing agent protects the therapeutic protein from denaturation during the encapsulation process. In addition to being immunogenic, when administered orally, encapsulated allergen has a therapeutic effect in the treatment of human allergies.
Patent NZ-275315-A (NZ)
Title: N-acylated-n'-phenyl-alpha-amino acid carboxamide derivatives; pharmaceutical compositions
Inventor: CASTELHANO ARLINDO L
IPC: C07C271/22
Filed: 1994-11-03
Abstract: This invention is directed to compounds of formula (I): wherein R<1> is mercapto, acetylthio, carboxy, hydroxycarbamoyl, alkoxycarbonyl, aryloxycarbonyl, aralkoxycarbonyl, benzyloxycarbamoyl or (i) (where R<6> is optionally substituted aryl, wherein the aryl group is quinol-2-yl, naphth-1-yl, naphth-2-yl, pyridyl or phenyl); R<2> is alkyl, aralkyl or cycloalkylalkyl; R<3> is cycloalkyl, alkyl (optionally substituted by cycloalkyl, hydroxy, mercapto, alkylthio, aralkoxy, carboxy, amino, alkylamino, guanidino, carbamoyl, pyridyl or indolyl), or aralkyl (optionally substituted by hydroxy, carboxy, alkyl or alkoxy); R<4> is nitro, amino, cyano, hydroxy, alkoxy, carboxy, alkoxycarbonyl, alkylsulfonyl, haloalkyl, alkoxycarbonylalkyl, tetrazolyl, carbamoyl (optionally substituted by alkyl or dialkylaminoalkyl), or aminosulfonyl (optionally substituted by alkyl); and R<5> is hydrogen, halo or hydroxy; as single stereoisomers or as mixtures thereof; or the pharmaceutically acceptable salts thereof. These compounds are useful in inhibiting matrix metalloprotease activity in mammals.
Patent NZ-291423-A (NZ)
Title: 5-(azetidin-1-ylalkyl)-2-piperidone lactams as tachykinin antagonists and intermediates thereof
Inventor: MACKENZIE ALEXANDER RODERICK
IPC: A61P43/00
Filed: 1995-07-29
Abstract: PCT No. PCT/EP95/03054 Sec. 371 Date Feb. 10, 1997 Sec. 102(e) Date Feb. 10, 1997 PCT Filed Jul. 29, 1995 PCT Pub. No. WO96/05193 PCT Pub. Date Feb. 22, 1996The present invention provides compounds of formula (I) and the pharmaceutically acceptable salts thereof, wherein R is C3-C7 cycloalkyl, aryl or C1-C6 alkyl, said C1-C6 alkyl, said C1-C6 alkyl being optionally substituted by fluoro, COOH, -COO(C1-C4 alkyl), C3-C7 cycloalkyl, adamantyl, aryl or het1, and said C3-C7 cycloalkyl being optionally substituted by 1 or 2 substituents each independently selected from C1-C4 alkyl, C3-C7 cycloalkyl, C1-C4 alkoxy, hydroxy, fluoro, fluoro (C1-C4) alkyl and fluoro (C1-C4) Alkoxy; R1 is phenyl, naphthyl, thienyl, benzothienyl or indolyl, each optionally substituted by 1 or 2 substituents each independently selected from C1-C4 alkyl, C1-C4 alkoxy, halo and trifluormethyl; R2 is -CO2H, -CONR3R4, -CONR5(C3-C7 cycloalkyl), -NR5(C2-C5 alkanoyl), -NR3R4, -NR5CONR5R6, (C3-C7 cycloalkyl-C1-C4 alkyl)R5N-, -NR5COCF3, -NR5SO2CF3, -NR5(SO2 C1-C4 alkyl), -NR5SO2NR5R6, -NR5(SO2 aryl), -N(aryl) (SO2C1-C4 alkyl), -OR5, -O(C3-C7 cycloalkyl), -SO2NR5R6, het3 or a group of formulas: (a), (b), (c), (d), (e), (f), (g) or (h); X is C1-C4 alkylene; X1 is a direct link or C1-C6 alkylene; X2 is a direct link, CO, SO2, or NR5CO; and m is 0, 1 or 2; together with intermediates used in the preparation of compositions containing and the use as tachykinin angatonists of such derivatives.
Patent NZ-305959-A (NZ)
Title: HA-2 antigenic peptide
Inventor: GOULMY ELS A J M
IPC: C12N5/08
Filed: 1996-04-25
Abstract: The present invention discloses the first peptide sequence of a so-called minor H antigen. The minor H antigens are associated with the Graft versus Host Disease. The peptide and its derivatives find many uses in bone marrow transplantation, organ transplantation and in the treatment of leukemia. The peptide and its derivatives can be incorporated in vaccines, in pharmaceutical formulations and they can be used in diagnostic test kits. The peptide is derived from the HA-2 minor antigen and has the sequence YXGEVXVSV, wherein X represents a leucine or an isoleucine residue. Both donors and recipients in bone marrow transplantation can be treated with the peptides, optionally in combination with other peptides, coupled to carriers, with suitable excipients and/or adjuvants.
Patent NZ-307883-A (NZ)
Title: Videophone interactive mailbox facility system comprising a central data centre to receive information from a vendor and user station
Inventor: DAVIDSOHN JOHN
IPC: G06Q30/06
Filed: 1996-05-09
Abstract: A videophone interactive mailbox facility system (10) is disclosed for processing of information to conduct a transaction which includes a user station (100), a vendor station (300) and a central data center (200). The user station (100) has a videophone (120) for viewing information sent or received to conduct a transaction; an encryption encoder (180) and a decryption decoder (182) for safeguarding the information sent or received; and a touch pad for inputting the information into the videophone (120). The vendor station (300) has a computer for the transmission and receipt of vendor-type information to or from the central data center (200) for conducting a transaction; and an encryption encoder and a decryption decoder for message privacy and transaction authentication of the information sent or received. The central data center (200) is electronically connected to the user station (100) and to the vendor station (300) and includes a computer processor for centralized transmitting, receipt of and storage of all information and transactions with the user station and the vendor station. The computer is electronically connected to one or more telephones and also includes a display screen for monitoring the transactions. Also included is an encryption encoder and a decryption decoder for authentication of the information sent or received, and a network interface for
Patent NZ-329613-A (NZ)
Title: Preparation of synthesis gas by steam reforming of a hydrocarbon feedstock through tubular reactors using a thin film catalyst
Inventor: ROSTRUP-NIELSON JENS
IPC: C01B32/40
Filed: 1998-01-21
Abstract: Process for the preparation of hydrogen of carbon monoxide rich gas by steam reforming of a hydrocarbon feedstock in presence of a steam reforming catalyst supported as thin film on a tubular reactor, comprising steps of   (a) optionally passing a process gas of prereformed hydrocarbon feedstock through a first tubular reactor with a thin film of steam reforming catalyst supported on walls of the reactor in heat conducting relationship with hot flue gas from a subsequent second tubular steam reforming reactor; (b) passing effluent from the first tubular reactor to the subsequent second tubular reactor being provided with a thin film of the steam reforming catalyst and being heated by burning of fuel, thereby obtaining a partially steam reformed gas effluent and the hot flue gas; (c) passing the effluent from the second reactor to a fixed bed steam reforming catalyst; and (d) withdrawing from the fixed bed a product gas of the hydrogen and carbon monoxide rich gas.
Patent NZ-332514-A (NZ)
Title: Diagnostic composition containing urea for detecting the presence of Helicobacter pylori through the presence of ammonia in the exhaled breath
Inventor: NYSTROM CHRISTER
IPC: A61K49/00
Filed: 1997-04-18
Abstract: A medical preparation for demonstrating the presence of urease activity in the stomach in conjunction with Helicobacter pylori infection by demonstrating the presence of formed ammonia in exhalation air is claimed. The preparation comprises a solid substantially water free composition that contains non-isotopically labeled urea, which is influenced by the activity of Helicobacter pylori to form ammonia.
Patent NZ-333493-A (NZ)
Title: Method of evacuating a patient's colon by oral administration of an osmotic colonic evacuant in powder form
Inventor: BORODY THOMAS JULIUS
IPC: A61K33/04
Filed: 1996-11-01
Abstract: An orthostatic lavage solution or colonic evacuant for cleaning the gastrointestinal tract, or for the treatment of bowel disease and/or disorders. The colonic evacuant in powder form comprises of a phosphate or sulphate based laxative.
Patent NZ-334339-A (NZ)
Title: A process of modifiying cellulose production, increasing stress resistance or increasing plant growth and yield in plants by inserting a DNA sequence encoding a product which modifies the level of cellulose precursors in the plant
Inventor: ELLIS DAVID DUNHAM
IPC: C12N9/12
Filed: 1997-09-09
Abstract: The process of increasing plant growth and yield comprises introducing into a plant a DNA sequence encoding a product such as an enzyme, protein or RNA that modifies the level of cellulose precursors in the plant. The process of modifying the production of cellulose in a plant or increasing the resistance of a plant to stress comprises introducing into and expressing in the plant a DNA sequence encoding a product such as an enzyme, protein or RNA that modifies the level of cellulose precursors in the plant. The DNA sequence preferably can comprise the UDPG-PPase gene.
Patent NZ-336042-A (NZ)
Title: Farnesyl transferase inhibitors
Inventor: BOURZAT JEAN-DOMINIQUE
IPC: C07D403/04
Filed: 1997-12-23
Abstract: Farnesyl transferase inhibitors, particularly, benzoperhydroisoindole compounds of formula I in which the substituents are as described in the specification, and process for its preparation.  Also disclosed are the intermediates important in the preparation of formula I.  The compounds produced according to the process claims have been found to be useful for the inhibition of farnesyl transferase and in treating diseases related to cell proliferations, especially cancer.
Patent NZ-500028-A (NZ)
Title: Stabilized human papillomavirus formulations also containing a salt and a nonionic surfactant
Inventor: SHI LI
IPC: A61K47/30
Filed: 1998-04-07
Abstract: A non-alum human papillomavirus vaccine formulation comprises a) a vaccine component such as human papillomavirus virus like particles; b) a salt present at a physiologically acceptable concentration and c) a non-ionic surfactant present at a physiologically acceptable concentration. The human papillomavirus virus like particle can be a L1 protein or L1 and L2 protein chosen from a group of 6a, 6b, 11, 16 and 18.  The salt can be sodium chloride and the surfactant can be polysorbate 80.
Patent NZ-500038-A (NZ)
Title: Improvements in and/or relating to flashings
Inventor: HAYNES ANDREW LEO
IPC: E04D13/14
Filed: 2000-09-28
Abstract: A flashing having at least one region thereof conformable as to shape, said flashing region comprising or including a weathering layer of a flexible material, a conformable yet shape retaining layer of a mesh like, perforate or other "open" character material, and a tack retaining adhesive matrix bonding to said conformable layer and to said flexible material.
Patent NZ-502063-A (NZ)
Title: Reconfiguration of a cellular telephone network
Inventor: BARK ANNA-SOFIE
IPC: H04W24/02
Filed: 1998-08-19
Abstract: A method of reconfiguration in a cellular telephone network comprises the steps of: storing each of a plurality of predefined cell profiles (a set of cell parameters) in each of (a) a database at a control location, and (b) respective databases at each of a plurality of base station controllers; selecting one of the prestored cell profiles for use in reconfiguring at least a system of the network, wherein the step of selecting one of the prestored cell profiles is performed using the database at the control location; sending a command to at least one base station controller affected by the reconfiguration indicating which of the prestored cell profiles was selected in the selecting step; and retrieving the cell profile indicated by the command from a database in the at least one base station controller, so that the entire prestored cell profile need not be transmitted to the at least one base station controller from the control location during the reconfiguration.
Patent NZ-503639-A (NZ)
Title: Communications network node
Inventor: GITTINS CHRISTOPHER JOHN
IPC: H04Q3/545
Filed: 1998-10-14
Abstract: A node which, provides a network-based information service, in an intelligent communications network. The node being arranged to store customer identities, respective customer-associated lists of identities of information items (hereinafter referred to as items) for which the respective associated customer has access rights and identities of item-associated information sources which store the respective items. The node also being arranged to respond to a message from a customer requesting access to the information service and indicating an item, which the customer wants retrieved, by ascertaining whether the requested item is on the customer's list. If the item appears on the customer list the node retrieves the item from its respective source, and sends it to the customer. If the message does not contain an item identity, the list of items is sent to the customer for him to make a selection.
Patent NZ-506471-A (NZ)
Title: Cathode used for preparing an alkaline metal chlorate and method for making same
Inventor: ANDOLFATTO FRANCOISE
IPC: C25B1/26
Filed: 1999-02-11
Abstract: The invention relates to a specific cathode comprising a  substrate made of an element chosen from the group formed by   titanium,  nickel,  tantalum,  zirconium,  niobium  and alloys  thereof,  the said substrate being  coated  with  an interlayer  of  a  mixed  oxide based  on  titanium  and  on ruthenium  and  with  an  external  layer  of  metal  oxides comprising  titanium, zirconium and ruthenium.  The  subject of  the invention is also its manufacturing process and  its applications in electrolysis.